These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28575121)

  • 21. Impact of pharmacodynamics and pharmacokinetics on echinocandin dosing strategies.
    Gumbo T
    Curr Opin Infect Dis; 2007 Dec; 20(6):587-91. PubMed ID: 17975408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of echinocandin regimens by pharmacokinetic/pharmacodynamic analysis against Candida spp. in paediatric patients.
    Xu G; Zhu L; Liao S; Ge T; Yang J
    Int J Antimicrob Agents; 2015 Dec; 46(6):631-41. PubMed ID: 26602452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients.
    Walsh TJ; Goutelle S; Jelliffe RW; Golden JA; Little EA; DeVoe C; Mickiene D; Hayes M; Conte JE
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3451-9. PubMed ID: 20439610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics/Pharmacodynamics of Caspofungin in Plasma and Peritoneal Fluid of Liver Transplant Recipients.
    Pressiat C; Ait-Ammar N; Daniel M; Hulin A; Botterel F; Levesque E
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0118721. PubMed ID: 34662185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspergillus felis sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogs.
    Barrs VR; van Doorn TM; Houbraken J; Kidd SE; Martin P; Pinheiro MD; Richardson M; Varga J; Samson RA
    PLoS One; 2013; 8(6):e64871. PubMed ID: 23798996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.
    Warn PA; Sharp A; Morrissey G; Denning DW
    Int J Antimicrob Agents; 2010 Feb; 35(2):146-51. PubMed ID: 20015618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and Pharmacodynamic Comparison of Intravenous and Inhaled Caspofungin.
    Yu IG; O'Brien SE; Ryckman DM
    J Aerosol Med Pulm Drug Deliv; 2021 Jun; 34(3):197-203. PubMed ID: 32985935
    [No Abstract]   [Full Text] [Related]  

  • 28. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
    Keating G; Figgitt D
    Drugs; 2003; 63(20):2235-63. PubMed ID: 14498760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single or 2-Dose Micafungin Regimen for Treatment of Invasive Candidiasis: Therapia Sterilisans Magna!
    Gumbo T
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S635-42. PubMed ID: 26567282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of minimum inhibitory and minimum effective concentration values for the detection of in vitro susceptibilities of Aspergillus species against caspofungin].
    Ozkütük A; Metin DY; Ergon C; Yücesoy M; Hilmioğlu PS
    Mikrobiyol Bul; 2007 Apr; 41(2):285-90. PubMed ID: 17682716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics and pharmacodynamics of caspofungin in pediatric patients.
    Li CC; Sun P; Dong Y; Bi S; Desai R; Dockendorf MF; Kartsonis NA; Ngai AL; Bradshaw S; Stone JA
    Antimicrob Agents Chemother; 2011 May; 55(5):2098-105. PubMed ID: 21300834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of pharmacokinetic drug interaction between oral posaconazole and caspofungin or micafungin.
    Krishna G; Vickery D; Ma L; Yu X; Noren C; Power E; Beresford E; Medlock M
    J Clin Pharmacol; 2011 Jan; 51(1):84-92. PubMed ID: 20489029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of caspofungin increased dosage in a patient on rifampin-containing anti-tubercular treatment.
    Calcagno A; Baietto L; Pagani N; Bertucci R; Rostagno R; D'Avolio A; Di Perri G; De Rosa FG
    Scand J Infect Dis; 2013 Nov; 45(11):882-4. PubMed ID: 23796067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation.
    Groetzner J; Kaczmarek I; Wittwer T; Strauch J; Meiser B; Wahlers T; Daebritz S; Reichart B
    J Heart Lung Transplant; 2008 Jan; 27(1):1-6. PubMed ID: 18187079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Very-high-dose caspofungin combined with voriconazole to treat central nervous system aspergillosis: substantial penetration of caspofungin into cerebrospinal fluid.
    Réminiac F; Sonneville R; Massias L; Chochillon C; Wolff M
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3568-9. PubMed ID: 24733459
    [No Abstract]   [Full Text] [Related]  

  • 37. Maintenance of therapeutic concentrations of caspofungin after temporary treatment interruption (48 hours) in a child with invasive aspergillosis.
    Castagnola E; Cappelli B; Faraci M; Fallani S; Cassetta MI; Novelli A
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3775. PubMed ID: 17646422
    [No Abstract]   [Full Text] [Related]  

  • 38. Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species.
    Antachopoulos C; Meletiadis J; Sein T; Roilides E; Walsh TJ
    Antimicrob Agents Chemother; 2007 Mar; 51(3):881-7. PubMed ID: 17145783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fungal Rhinosinusitis and Disseminated Invasive Aspergillosis in Cats.
    Barrs VR; Talbot JJ
    Vet Clin North Am Small Anim Pract; 2020 Mar; 50(2):331-357. PubMed ID: 31866094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of micafungin in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Oshima K; Kanda Y; Kako S; Ohno K; Kishino S; Kurokawa M
    Transpl Infect Dis; 2013 Jun; 15(3):323-7. PubMed ID: 23578224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.